Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization

RIYADH, Saudi Arabia, Jan. 11, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has announced today its ProBeam® proton therapy system is the first such system to receive Saudi FDA medical devices marketing authorization.

"We are pleased to have the opportunity to make life-saving proton therapy treatments available to cancer patients in this region," said Moataz Karmalawy, general manager of Varian's particle therapy business.

Proton therapy makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The method can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients the risk of developing a new, radiation-induced cancer later in life can be reduced.

Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland. Varian also has contracts for system installations at 13 other sites around the world.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for x-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of x-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 7,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit www.varian.com or follow us on Twitter.

Press Contact

Neil Madle
Varian Medical Systems
+44 7786 526068
[email protected]

SOURCE Varian Medical Systems

Related Links

http://www.varian.com